Introduction
Highly specialized cells, such as hormone producing cells, produce one or two peptides at much higher rates than all other cellular proteins. Little is known on the mechanism of selectivity of this process. In pancreatic β-cells glucose metabolism affects most major signal pathways, including those of insulin production, storage and exocytosis [1, 2] . Multiple families of protein kinases are known to function downstream to glucose metabolism; however the precise role of many is poorly defined [3] . Several subtypes of these kinases are also activated by receptor-generated signals and thus may function as the site of convergence of the metabolic signals with those generated by hormones and neurotransmitters. When activated, many protein kinases, including the protein kinase C family, translocate to the site of their effectors and bind an anchoring protein which keeps them in close proximity of their downstream target [4] . We identified six isoforms of PKC in rat β-cells, four of which, PKCα, PKCε, PKCζ and PKCθ, exhibited glucose-induced activation and translocation [5] .
Abnormalities in level or translocation characteristics in response to glucose were observed for PKCα, PKCε, PKCζ, PKCδ, and PKCθ in β-cells of the GK rat, a rodent with spontaneous type 2-like diabetes [5] . Using anchoring-competing short peptides, we have also shown that inhibition of translocation of PKCα and PKCε diminishes insulin release from isolated rat islets, the former in a calcium-dependent mode and the latter in a calcium-independent manner [6] .
Histochemical analyses indicated a strong association of PKCα and PKCε with insulin granules and with their movements during the biphasic dynamics of glucose-induced insulin secretion [5] . In other cells, PKCε has been reported to play an essential role in diverse signaling systems related to cell proliferation [7] [8] [9] [10] , gene expression [7, 10] , and vesicle trafficking and exocytosis [10] . β′COP-1, or RACK2, which is a member of the COP complex involved in the shuttling of newly formed proteins, has been identified as PKCε's anchoring protein [10, 11] and is responsible for maintaining the activated form of the enzyme in close proximity of its effector protein(s) [4, 12] . Because we observed that glucose stimulation led to concentration of PKCε in the perinuclear region in β-cells [5] , in the present study we explored the role of PKCε in insulin production and secretion in rat islets of Langerhans. 100 mg/kg thiopentone sodium, the pancreas quickly isolated and prepared for perfusion as previously described [13, 14] . The pancreas was fixed with 4% formaldehyde in PBS by a brief perfusion, and kept at 4°C in PBS until staining and imaging [5, 15] .
Islets
Rat islets were isolated by collagenase digestion (Collagenase P; Roche, Boehringer-Mannheim, Mannheim, Germany) as previously described [14] , hand picked and washed 3 times in Hanks solution. Islets were cultured in bacteriological dish in RPMI 1640 medium, containing 10% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 2.0 mmol/l L-Glutamine (all from Biological Industries, Beit Haemek, Israel).
Immunohistochemical staining and imaging
Pancreata were sectioned, stained and imaged using a Zeiss LSM 410 confocal laser scanning system attached to the Zeiss Axiovert 135 M inverted microscope as previously described [5] . Antibodies for PKCε histochemistry and for Western blot were obtained from Sigma-Aldrich Biochemicals (Rehovot, Israel).
siRNA
Double-strand 21 mer siRNA (siR-PKCε) was designed as described in detail by Elbashir et al. [16] (Fig. 1A ) and ordered from Dharmacon (Dharmacon Inc. Chicago, IL). The DS Scrambled Negative was from IDT (Integrated DNA Technologies, Coralville, IA). DS siRNA-containing micelles were prepared by mixing 5 µl Lipofectamine 2000 (Invitrogen Corporation, Carlsbad, California, USA) and 100 µl OptiMEM (Invitrogen) and transfected as described by the manufacturer in an antibiotic-free medium. The final concentration of siRNA was 100 nmol/l. Transfection medium was replaced after 6 h with the regular growth medium (RPMI), and the islets were maintained in culture for three additional days. Efficiency of penetration was monitored in INS-1E cells using 5'-Cye3 labeled inactive construct (Dharmacon) followed by FACS analysis 16 h after transfection, and was routinely N 94%. In isolated islets, the efficiency was monitored by confocal imaging of the same construct using 5 µm apart z-plane sections ( Supplementary Fig. 1 ). Efficiency of PKCε shutoff was estimated by Western blot and densitometric analysis using Tina 2.0 Image Analysis software (an open source library and toolkit), and ranged between 60% and 80% ( Fig. 2A ).
Expression of PKCε
The adenoviruses expressing kinase-dead PKCε (PKCε-KD) or authentic PKCε ( [17] ( Fig. 1B) were kindly provided by Drs. T. Kuroki, Showa University, Tokyo and T. Tennenbaum, Bar-Ilan University, Israel. The virus was propagated in HEK 293 cells grown in DMEM medium (Biological Industries). Freshly isolated islets were infected with 200 IFU/islet in RPMI medium (Biological Industries) and incubated overnight at 37°C. Levels of PKCε expression were determined by Western blot using anti-PKCε antibody (Sigma, see Section 2.3 above) and islets treated with control adenovirus were used as reference for basal levels of PKCε. Reduction in novel PKC activity in islets infected with PKCε-KD was 70% ( Fig. 2B ), determined by SignaTECT PKC Activity Assay (Promega, Madison WI). For novel PKC activity assay, endogenous phospholipids were removed by DE52 column extractions and calcium was excluded using EGTA, thus eliminating the contribution of the Classical family of isoenzymes. The activity of the atypical family of isoenzymes was subtracted using duplicate extracts activated by phospholipids alone. Data shown in Fig. 2B are the net DAG-activated fractions, in the Fig. 1 . A-C: The three unrelated procedures used to diminish PKCε activity in rat pancreatic β-cells. A: The RNAi, siR-PKCε; B: the expression of inactive PKCε, PKCε-KD; C: map of the adenovirus expressing a short peptide that competes with PKCε for RACK2, εV1-2, a translocation-inhibitory peptide generated from the V1 region of PKCε [11] . The scrambled sequence is also illustrated. presence of phosphatidylserine, after subtraction of the activity determined with phosphatidylserine and without DAG.
Translocation-inhibitory peptides
Plasmids coding for PKCε translocation-inhibitory peptide (εV1-2) and for scrambled control (εV1-2s) were kindly provided by Dr. D. Mochly-Rosen, Stanford University, CA, and inserted into adenoviral vectors. Single-strand nucleotide sequences for peptides generated from the V1 region of PKCε and for the scrambled controls were inserted into pEGFP-C1 adenoviral vector as described in detail by He et al. [18] ( Fig 1C) .
Insulin synthesis
Batches of 25 islets were used in a final volume of 500 μl to study total protein and proinsulin biosynthesis. Islets were preincubated in 3.3 mmol/l glucose for 60 min, then further incubated for 1 h in Krebs Ringer Bicarbonate (KRB) solution containing 16.7 mmol/l glucose, then for an additional 15 min in the same buffer supplemented with 25 μCi 3 H-leucine (leucine, L-2, 3, 4, 5-3 H, American Radiolabeled Chemicals, Inc., St. Louis, MO). For proinsulin processing studies, following the labeling period, the medium was changed to KRB with 3.3 mmol/l glucose supplemented with 1.0 mmol/l non-labeled leucine. The studies were terminated by the addition of 1.0 ml glucose-free KRB solution, centrifugation, and addition of 500 μl GB/NP40 buffer (0.2 mol/l glycine buffer containing 0.1% RIA grade BSA and 0.5% NP-40, pH 8.8) to the precipitate. For determination of total insulin I + II plus proinsulin, 50 ml samples were pre-treated with 4.5 mg Protein A-Sepharose beads (Sigma-Aldrich) in 100 μl of GB/NP40 buffer by shaking at room temperature for 1 h. After centrifugation (1000 RPM, 1 min), the supernatant was transferred to fresh beads of Protein A-Sepharose, suspended in GB/ NP40 buffer; anti-insulin antibody (1/25 dilution, Sigma-Aldrich) was added, and the mix was incubated using gentle shaking for 1 h at room temperature. The antiserum (Sigma I-8510) was evaluated for cross-reactivity with proinsulin by comparing the labeled insulin + proinsulin recovered by immunoprecipitation and by RP-HPLC in identical samples. Incubation was terminated by centrifugation at 1000 RPM for 1 min, two washes of the precipitate with GB/NP40 buffer, and the addition of 100 μl water. Scintillation fluid (4.5 ml, QuickSafe A, Zinsser Analytic, Frankfurt, Germany) was added and the sample was counted using TriCarb 1500 beta counter (Packard Instrument, Downers Grove, IL). Production of insulin and insulin intermediates was determined by the RP-HPLC separation protocol as described by Gadot et al. [14] modified after Halban et al. [19] and Zambre et al. [20] . For the determination of total newly synthesized protein, 0.5 ml of 0.1% BSA was added to 20 ml of sample, followed by 0.5 ml 20% trichloroacetic acid (TCA). Following 20 min of standing on ice, the sample was washed twice with 10% TCA by filtration through a Whatman GF/A filter, dried, and counted in 8 ml QuickSafe A as above.
Insulin assay
In dynamic islet perifusion studies, basal samples (2.5 mmol/l glucose) were collected every 5 min, then during glucose stimulation (16.7 mmol/l) every minute for the first 10 min, followed by 5 min collections for the rest of the study. Net area under the curve (AUC) insulin released during the initial 6 min of stimulation was calculated for 1st phase insulin response and for 2nd phase insulin release, the subsequent 60 min was used. Insulin was determined using Rat Insulin RIA kit (Linco Research, St. Charles, Missouri, USA). Mean CV between assays was 8.9%, within assay 2.2%.
Statistical analyses
Kruskal-Wallis nonparametric ANOVA followed by Tukey-Kramer test was used to compare between the experimental conditions with 95% confidence level. Data was analyzed using InStat statistical software (GraphPad Software, San Diego, CA).
Results

Inhibition of PKCε reduces insulin release
Using cultured rat islets or mouse β-cells, we [6] as well as Mendez et al. [21] have shown that PKCε plays a role in the insulin response to glucose. To further elucidate the role of PKCε in the dynamics of insulin response to glucose, we employed two unrelated approaches in isolated rat islets to diminish endogenous PKCε activity: expression of inactive PKCε (PKCε-KD) and depletion of PKCε by siRNA (siR-PKCε). Fig. 3 shows that the two approaches resulted in similar results. Expression of PKCε-KD at 5 fold basal levels, resulting in 70% inhibition of novel PKC activity (Fig. 2B ), led to inhibition of the insulin response to glucose (Fig. 3A) . Likewise, diminished PKCε levels using siR-PKCε (routinely between 60% and 80% reduction, Fig. 2A ), led to a similar inhibition of the insulin response to glucose (Fig. 3B ). Basal rates of insulin release were unaffected by infection with adenovirus expressing PKCε-KD or by transfection with siR-PKCε: in control, non-treated islets, basal insulin secretion was 0.26 ± 0.06 ng/50 islets/min; in islets transfected with scrambled siRNA, 0.29 ± 0.07 ng/50 islets/min; in islets transfected with siR-PKCε, 0.35 ± 0.09 ng/50 islets/min; in islets infected with adenovirus expressing PKCε-KD, 0.30 ± 0.09 ng/50 islets/min; in islets infected with adenovirus expressing PKCε-WT, 0.20 ± 0.06 ng/50 islets/min (none significantly different). No change in insulin response was observed in islets infected with adenovirus over-expressing authentic PKCε (PKCε-WT) as compared with untreated islets (Fig. 3A) , indicating that in nontreated islets, the enzyme was not rate-limiting in the exocytotic pathway. Transfection with an inactive (scrambled) construct of siRNA had no significant effect on rates of insulin response to glucose. Integrated evaluation (AUC) of the phasic response to glucose (Table 1) revealed a modest, but non-significant, decline of 1st phase insulin response (6 min) to glucose by treatment with either PKCε-KD or siR-PKCε. A significant decline in insulin response was seen in AUC during the 2nd phase (subsequent 1 h): the expression of PKCε-KD resulted in nearly 80% decline in insulin release and transfection with siR-PKCε resulting in 83% inhibition (Table 1) .
Localization of activated PKCε
ß'COP1, a component of the COP1 trafficking complex was reported to be a specific anchoring protein for PKCε [11] This led us to consider the possibility that the inhibitory effect of PKCε on glucose-dependent insulin release could be related to a reduction in insulin production. The pool of newly synthesized hormone is known to be preferentially released upon glucose stimulation [22] [23] [24] [25] . Fig. 4 shows that 15 min of stimulation of the isolated perfused rat pancreas with 16.7 mmol/l glucose resulted in concentration of the activated enzyme in granulated structures in the perinuclear region, known to be rich in ER and Golgi membranes. Within this short time frame, the majority of these perinuclear structures exhibited a signal super-imposable with insulin (or proinsulin), indicative of association with the insulin producing or storing structures. Forty-eight fields obtained from random sections of 4 control and 4 glucose-stimulated pancreata were imaged; 67% fields of pancreatic islets displayed glucose-induced β-cell perinuclear concentration of PKCε in association with insulin staining.
PKCε controls biosynthetic pathways
Given that PKCε localized to insulin-staining structures in the perinuclear regions, we next determined its role in the pathways of insulin production. Rat islets were infected with adenovirus expressing PKCε-KD, or εV1-2, stimulated with glucose for 75 min and pulselabeled with 3 H-leucine for the final 15 min as described. Immediately at the end of the 75 min glucose stimulus, total islet proteins were extracted and subjected to immunoprecipitation with anti-insulin antibodies, or loaded on RP-HPLC for analysis of newly produced insulin-like products. At the end of 15 min labeling (0 time), the radioactivity recovered in the HPLC proinsulin peaks in non-infected control islets was 76,103 ± 22,326 DPM/25 islets, N = 8; in infected control islets expressing EGFP alone, 79,399 ± 12,608 DPM/25 islets were measured, N = 6; in infected control islets expressing εV1-2s, 108,840 ± 16,234 DPM/25 islets were measured, N = 5, (means ± SEM, none significantly different). The insulin antibody was selected for its full cross-reactivity with proinsulin (see Materials and methods), therefore the products obtained by precipitation at the end of 15 min labeling would mostly be proinsulin. Islets expressing PKCε-KD produced 50% less proinsulin following the 15-min labeling, as compared to control islets as shown in Fig. 5A (p b 0.01) . The expression of inactive PKCε had no effect on total glucose-stimulated protein synthesis ( Fig 5B) (p = NS). Similarly, at the end of the glucose stimulation, newly formed insulin-related products in islets infected with adenovirus expressing εV1-2 were more than 60% less than that observed in islets infected with adenovirus expressing the scrambled form of the peptide, εV1-2s (p b 0.01) (Fig. 5C ).
PKCε regulates proinsulin conversion to insulin
We next examined whether PKCε was also involved in the conversion of proinsulin to mature insulin I and II. Isolated rat islets were infected with adenovirus expressing the RACK2-competing peptide (εV1-2), and stimulated with 16.7 mmol/l glucose for 75 min; the final 15 min was pulsed with 3 H-leucine, then a 90-min chase period with 3.3 mmol/l glucose and 1.0 mmol/l leucine was applied (for details see Materials and methods). Islet proteins were analyzed by RP-HPLC as outlined [14, 26] . The overall labeling in the control proinsulin peaks was 107,567 ± 10,170 DPM/25 islets in the non-treated islets; 99,062 ± 11,330 DPM/25 islets in islets infected with adenovirus expressing EGFP alone and 127,125 ± 19,187 DPM/25 islets in islets expressing the εV1-2s peptide (means ± SEM, none significantly different). Fig. 6 presents the mean data of the individual peaks obtained in 7-11 studies, illustrating the relative amounts of proinsulin, insulin I + II, C-peptide and the insulin-related conversion intermediates detected at the end of the 90-min chase period. Diminished glucose-induced translocation of PKCε by εV1-2 led to a reduction in C-peptide and a small decrease in insulin fractions (insulin I + insulin II) compared to control islets or as compared with islets infected with adenovirus expressing the scrambled peptide, εV1-2s. These changes were significant for C-peptide (p b 0.05) but not for insulin. Most significantly, the expression of εV1-2 resulted in the doubling of the fraction of proinsulin as compared to control (16% ± 3% vs. 8% ± 1%) or to islets expressing εV1-2s (16% ± 3% vs. 8% ± 2%) (both p b 0.05). Finally, insulin-related conversion intermediates were also somewhat increased as compared to control islets or to islets expressing the scrambled peptide εV1-2s (22% ± 4% vs. 15% ± 2% control; 22% ± 4% vs. 13% ± 2% for εV1-2 vs. εV1-2s) (both NS). This analysis suggests that PKCε may affect two sites: the transport of proinsulin to the TGN, as well as its movement within the TGN, thus affecting its anterograde trafficking and the processing to mature insulin. The study also demonstrates that adenoviral infection and the expression of scrambled peptide had no effect on the synthesis of any of the insulinrelated materials.
Discussion
Glucose metabolism controls the most essential functions in pancreatic β-cells through multiple complex pathways (reviewed in [1, 2] ). Several protein kinases play key functions in these cells, many also serve as cross points for signals originating from glucose metabolism and from activated receptors. Insulin synthesis as well as the synthesis of most other β-cell proteins is regulated by glucose metabolism; many components of this pathway are poorly defined. Glucose-enhanced overall protein synthesis has been linked with dephosphorylation of eIF2a and the formation of eIF2-GTP-Met-tRNA initiation complex [27] , but the post-translational mechanism of glucose-selective production of insulin, a major component of the β-cell, is unknown. We have shown that glucose activated at least 6 isoforms of the PKC family, each with a unique kinetics and specific localization [5, 6] . At the onset of the 1st phase (2 min), glucose-triggered co-localization of PKCε and insulin was observed near the β-cell membrane and subsequently, during the 2nd phase (N15 min) in the perinuclear region [5] . The latter persisted for more than 15 min following the cessation of the glucose stimulus. Stimulus-induced localization of PKCε to the ER-Golgi complex was reported in other cells (reviewed in [10] ), and importantly, β′COP1, a vesicular trafficking protein, was the first specific anchoring protein (RACK2) identified for PKCε [11, 28, 29] .
We next considered that the effect of inhibition of PKCε targeted the newly synthesized insulin, a pool of hormone preferentially released upon glucose stimulation [22] [23] [24] [25] . Thus, the identification of ß'COP1 as the specific anchoring protein for PKCε prompted us to investigate the role of PKCε in vesicular trafficking in pancreatic β-cells. Indeed, employing three unrelated mechanisms to diminish β-cell activity of PKCε we were able to show that PKCε is involved in glucose-driven synthesis of insulin. The effect was quite early in the biosynthetic route: when evaluated at time 0, immediately after a short pulse with 3 H-leucine, production of proinsulin was strongly diminished under both conditions of diminished PKCε activity. Furthermore, PKCε was apparently required for further steps of the transport and processing of proinsulin, since 90 min after the glucose pulse, fractional C-peptide was significantly reduced, whereas the related insulin I and II and intermediate insulin split products were reduced but to a lesser extent (not significantly). Correspondingly, the fraction of proinsulin doubled in islets with diminished PKCε activity. Thus, PKCε could be the important linking kinase between glucose metabolism and insulin production, exerting its control at an early post-translational level. Its specificity was demonstrated from the lack of PKCε-dependent effects on newly synthesized total proteins.
Glucose-induced re-localization of PKCε to an area rich in ER and the trans Golgi network (TGN) was previously observed, and clearly illustrated here using the rat perfused pancreas preparation. Double staining also confirmed association with insulin-containing structures. The dramatic depletion in proinsulin production implies that PKCε plays an important part in recognition or anterograde trafficking of the newly produced proinsulin from the ER to the TGN, prior to further processing and packaging. In fact, the specific binding to β′COP would position PKCε action at this site. The reduction of proinsulin at an early time, before processing by the convertase PC1/3 reaches significant level, may indicate that the reduced transfer of proinsulin from the ER to the TGN leads to translational block and the elimination of the newly synthesized protein. We have never observed localization of PKCε within the nucleus, and therefore a transcriptional inhibitory action seems unlikely.
The specific role played by PKCε in glucose-dependent insulin production raises the question of which linking signal originates from glucose metabolism. DAG, PIP3 and some fatty acids were reported as physiological stimuli of PKCε in other systems [10] . Subcellular localization of PKCε may partially depend on which second messenger binds to its C1 domain: in some systems translocation to the plasma membrane and cytoskeleton was induced by DAG and tridecanoic acids, whereas localization to the TGN was induced by arachidonic and linoleic acids [30] . In pancreatic β-cells, glucose metabolism is known to promote, directly or indirectly, the production of all four messengers. The association of PKCε with β′COP occurs at the C2 domain, the domain that also binds phospholipids [10] . This needs to be reaffirmed in pancreatic β-cells. The target protein within the biosynthetic machinery for activated PKCε is yet unclear. Several non-vesicular proteins were reported to be targets for activated PKCε, none yet linked to early or late shuttling of newly translated peptides.
Schmitz-Peiffer et al. recently reported improved glucose tolerance, increased insulin production and reduced insulin disposal in transgenic mice with total body PKCε knockout [31] . Albeit inconsistent with our data utilizing islet-specific targeting methodology, it is however, impossible to preclude that extended, overall PKCε knockout may induce or activate alternative, undetermined signal pathways in the islet. The report that increased insulin production was typically significant in mice fed high fat diet would support the assumption that additional, PKCε-unrelated signals could be potentiated in the PKCε −/− mice.
In summary, the data presented here suggests that PKCε plays an important role in the transport of newly synthesized proinsulin from the ER to the TGN. By affecting anterograde shuttling of the newly formed proinsulin, the enzyme may facilitate the processing of the prohormone to insulin. With interference in this function, diminished PKCε would overload the SER or ER with proinsulin, which would be promptly directed to a degradative pathway, resulting in diminished levels of proinsulin in that compartment. These effects of PKCε on the biosynthetic route of newly formed insulin may account for its indirect effect on glucose-triggered insulin secretion.
